Evidence map›Paper›PMID 40426850›Full record

ReviewBiomedicines2025

Novel Biomarkers in Hepatocellular Carcinoma from Embryogenic Antigens to cfDNA.

Robeer Ghantus, Răzvan Alexandru Ciocan, Diana Schlanger, Călin Popa, Claudia Diana Gherman, Călin Vaida, Bogdan Gherman, Doina Pîslă, Nadim Al Hajjar, Andra Ciocan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Robeer GhantusDepartment of Internal Medicine, Bnai Zion Medical Center, Haifa 31048, Israel.ORCID 0009-0009-0010-4583
Răzvan Alexandru CiocanDepartment of Surgery-Practical Abilities, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
Diana SchlangerRegional Institute of Gastroenterology and Hepatology "Octavian Fodor", 400162 Cluj-Napoca, Romania.
Călin PopaRegional Institute of Gastroenterology and Hepatology "Octavian Fodor", 400162 Cluj-Napoca, Romania.
Claudia Diana GhermanDepartment of Surgery-Practical Abilities, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400337 Cluj-Napoca, Romania.
Călin Vaida"CESTER" Research Centre for the Robot Simulation and Testing, Technical University Cluj-Napoca, 400114 Cluj-Napoca, Romania.ORCID 0000-0003-2822-9790
Bogdan Gherman"CESTER" Research Centre for the Robot Simulation and Testing, Technical University Cluj-Napoca, 400114 Cluj-Napoca, Romania.ORCID 0000-0002-4427-6231
Doina Pîslă"CESTER" Research Centre for the Robot Simulation and Testing, Technical University Cluj-Napoca, 400114 Cluj-Napoca, Romania.ORCID 0000-0001-7014-9431
Nadim Al HajjarRegional Institute of Gastroenterology and Hepatology "Octavian Fodor", 400162 Cluj-Napoca, Romania.
Andra CiocanRegional Institute of Gastroenterology and Hepatology "Octavian Fodor", 400162 Cluj-Napoca, Romania.ORCID 0000-0003-0126-6428

Funding

"New smart and adaptive robotics solutions for personalized minimally invasive surgery in cancer treatment-ATHENA" funded by the European Union-NextGenerationEU and Romanian Government under National Recovery and Resilience Plan for Romania 760072/23.05.2023, code CF 16/15.11.2022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpha-fetoproteincarcinoma biomarkersembryogenic antigenshepatocellular carcinoma

Identifiers

PMID40426850
PMCPMC12109373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.